These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22364797)

  • 1. Confounding and control of confounding in nonexperimental studies of medications in patients with CKD.
    Bradbury BD; Gilbertson DT; Brookhart MA; Kilpatrick RD
    Adv Chronic Kidney Dis; 2012 Jan; 19(1):19-26. PubMed ID: 22364797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic studies: pitfalls in interpretation.
    Westhoff CL
    Dialogues Contracept; 1995; 4(5):5-6, 8. PubMed ID: 12288680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.
    Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK
    Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis.
    Wolfe F; Flowers N; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 May; 29(5):1015-22. PubMed ID: 12022317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confounding in health research.
    Greenland S; Morgenstern H
    Annu Rev Public Health; 2001; 22():189-212. PubMed ID: 11274518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme.
    Soares CM; Diniz JS; Lima EM; Oliveira GR; Canhestro MR; Colosimo EA; Simoes e Silva AC; Oliveira EA
    Nephrol Dial Transplant; 2009 Mar; 24(3):848-55. PubMed ID: 18840891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjustment for missing confounders in studies based on observational databases: 2-stage calibration combining propensity scores from primary and validation data.
    Lin HW; Chen YH
    Am J Epidemiol; 2014 Aug; 180(3):308-17. PubMed ID: 24966224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of confounding bias in non-randomized studies by appropriate weighting.
    Schmoor C; Gall C; Stampf S; Graf E
    Biom J; 2011 Mar; 53(2):369-87. PubMed ID: 21308726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Roaming through methodology. XXXVII. Unintentional population stratification in genetic case-control studies].
    Hottenga JJ; Houwing-Duistermaat JJ; van Duijn CM
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):17-22. PubMed ID: 11802331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies.
    Groenwold RH; Hak E; Hoes AW
    J Clin Epidemiol; 2009 Jan; 62(1):22-8. PubMed ID: 18619797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and control of confounding in trauma research.
    Kurth T; Sonis J
    J Trauma Stress; 2007 Oct; 20(5):807-20. PubMed ID: 17955531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, confounding, and the illusion of statistical control.
    Christenfeld NJ; Sloan RP; Carroll D; Greenland S
    Psychosom Med; 2004; 66(6):868-75. PubMed ID: 15564351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of good causation studies.
    Daya S
    Semin Reprod Med; 2003 Feb; 21(1):73-83. PubMed ID: 12806562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An application of propensity score matching using claims data.
    Seeger JD; Williams PL; Walker AM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the objectives of and the approaches to propensity score analyses.
    Heinze G; Jüni P
    Eur Heart J; 2011 Jul; 32(14):1704-8. PubMed ID: 21362706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.